Remember Me
Or use your Academic/Social account:


Or use your Academic/Social account:


You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.


Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message


Verify Password:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Booker, A.; Heinrich, M. (2016)
Publisher: American Botanical Council
Languages: English
Types: Article
Subjects: UOWSAT
In recent years, the quality of botanicals has come under increased scrutiny. Despite the availability of numerous high-quality products from reputable companies, health care professionals, patients, and consumers are understandably concerned about questionable botanical ingredients in various consumer products. In Europe, this includes products that are generally unlicensed and unregistered supplements (also referred to as “botanicals”), which are often poorly regulated, or even totally unregulated, depending on the country of jurisdiction.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1. ABC-AHP-NCNPR Botanical Adulterants Program. Available at: http://cms.herbalgram.org/BAP/index.html. Accessed September 29, 2016.
    • 2. Bewicke C. The global botanical supply chain: How it works & do we get what we pay for? - A supplier's viewpoint. Talk presented at: The UNPA Raw Materials & Supply Chain Summit; February 23-24, 2016; Salt Lake City, UT. Available at: www.slideshare.net/SandyHays/unpa-2016-the-global-botanical-supply-chain-by-cal-bewicke-eni. Accessed September 29, 2016.
    • 3. European Parliament and the Council of the European Union. Directive 2004/24/EC of the European Parliament and of the Council of 31 March 2004 amending, as regards traditional herbal medicinal products, Directive 2001/83/EC on the Community code relating to medicinal products for human use. Official Journal of the European Union. April 30, 2004;L 136:85- 90.
    • 4. European Parliament and the Council of the European Union. Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use. Official Journal of the European Union. November 28, 2001;75(L 311):67-128.
    • 5. Fullbright. Product chain study: Orthodox tea. Commercial agriculture development project. Vol Final Report. Nepal: Ministry of Agriculture and Cooperatives, Department of Agriculture; 2008:1-31.
    • 6. Kaplinsky R. Competitions policy and the global coffee and cocoa value chain. United Nations Conference for Trade and Development (UNCTAD): United Nations; 2004.
    • 7. Recklies D. The Value Chain. Management Models and Tools. Vol 2013. Recklies Management Project GmbH; 2001. Available at: www.themanager.org/Models/ValueChain.htm. Accessed July 31, 2016.
    • 8. Booker A, Johnston D, Heinrich M. Value chains of herbal medicines - Research needs and key challenges in the context of ethnopharmacology. J Ethnopharmacol. 2012;140:624-633.
    • 9. Shahidullah AKM, Haque CE. Linking medicinal plant production with livelihood enhancement in Bangladesh: Implications of a vertically integrated value chain. J Transdisciplinary Environ Stud. 2010;9:1-18.
    • 10. Booker A, Jalil B, Frommenwiler D, et al. The authenticity and quality of Rhodiola rosea products. Phytomedicine. 2016;23:754- 762.
    • 11. Booker A, Suter A, Krnjic A, et al. A phytochemical comparison of saw palmetto products using gas chromatography and H1 NMR metabolomic profiling. Journal of Pharmacy and Pharmacolgy. 2014;66:811-822. doi:10.1111/jphp.12198.
    • 12. Booker A, Johnston D, Heinrich M. The welfare effects of trade in phytomedicines: A multi-disciplinary analysis of turmeric production. World Development. 2016;77:221-230.
    • 13. EMA. Uptake of the traditional use registration scheme and implementation of the provisions of Directive 2004/24/EC in EU member states. Patient Health Protection. London, UK: European Medicines Agency; 2013.
    • 14. Booker A, Frommenwiler D, Reich E, Horsfield S, Heinrich M. Adulteration and poor quality of Ginkgo biloba supplements. J Herbal Med. 2016;6(2):79-87.
    • 15. Do herbal supplements contain what they say on the label? Trust Me, I'm a Doctor. BBC Two website. Available at: www.bbc. co.uk/programmes/articles/4hX30rMYkMv9YjMTH38MY6/ do-herbal-supplements-contain-what-they-say-on-the-label. Accessed October 4, 2016.
    • 16. Alam G, Belt J. Developing a medicinal plant value chain: Lessons from an initiative to cultivate Kutki (Picrorhiza kurrooa) in Northern India. KIT Working Papers Series C5. Amsterdam: KIT; 2009.
    • 17. van de Kop P, Alam G, de Steenhuijsen Piters B. Developing a sustainable medicinal plant chain in India. Linking people, markets and values. In: Ruben R, Slingerland M, Nijhoff H, eds. Agro Food Chains and Networks for Development. Vol 16. Netherlands: Springer; 2006:191-237.
    • 18. Nelson V, Pound B. The Last Ten Years: A Comprehensive Review of the Literature on the Impact of Fairtrade. Natural Resources Institute (NRI); University of Greenwich: 2009.
    • 19. van Niekerk J, Wynberg R. The trade in Pelargonium sidoides: Rural livelihood relief or bounty for the 'bio-buccaneers'? Devel So Africa. 2012;29(4):530-547.
  • No related research data.
  • No similar publications.

Share - Bookmark

Download from

Cite this article